Open Demat Account
Become a
New
Partner
Financial
Services
Financial
Planning
Analyse
Portfolio
Investment
Platforms
Login
Flip
FundsGenie
Smartfolios
PMS
MyGeojit
Open Demat Account
Support
Equity
Mutual Funds
Portfolio Management
Currency Futures
IPO
Smartfolios
NEW
Sovereign Gold Bond
Commodity
Insurance
Depository Services
Global Investments
NEW
Margin Trading Funding
Private Wealth
NRI Services
Alternative Investment Funds
FundsGenie for Mutual Funds
Mutual Funds Sahi Hai!
Login to FundsGenie
Or Download the Mobile App
Equity
Margin Trading Funding
Smartfolios
NEW
Currency Futures
Depository Services
Commodity
IPO
Sovereign Gold Bond
To avail the service, you will be redirected to loans.geojitcredits.com
Continue
Close
Search
ALL
Company
News
NAV
Site Search
Please wait ...
Home
Equity
Index Details -Pharmaceuticals - Indian - Bulk Drugs & Formln
Share
Supriya Lifescience Ltd Share Price
Pharmaceuticals - Indian - Bulk Drugs & Formln
Buy
Ask Expert
Background
Balance sheet
Profit & Loss
Quarterly Results
Share Prices
Bonus History
Capital History
Key Financial Ratios
Director's Report
Score Board
Peer Comparison
Deliverable Volumes
NSE
BSE
612.20
612.10
Date :
Apr 02,2026 EOD
+11.20
(1.86 )
+1.57
(9.45 )
1D
1W
1M
3M
1Y
Stock Price Details
Open Price
(₹)
590.10
Buy (size)
0.00(x0)
Sell (size)
0.00(×0)
Buy Qty
0
Sell Qty
0
Today's High
(₹)
615.00
Today's Low
(₹)
583.95
52 Week High
(₹)
842.00
52 Week Low
(₹)
545.50
Market Statistics
Div Yield (%)
0.16
EPS
23.06
Book Value
134.41
Market Cap
4926.35
Face Value
2
Market Lot
1
AGM Date
Sep
Closure Date
ISIN No
INE07RO01027
Share Holding Pattern
Total Foreign (Promoter & Group)
0
Indian (Promoter & Group)
54967825
Total of Promoter
54967825
Non Promoter (Institution)
8214971
Non Promoter (Non-Institution)
17300004
Total Non Promoter
25514975
Total Promoter & Non Promoter
80482800
Custodians(Against Depository Receipts)
0
Grand Total
80482800
News
Supriya Lifescience Ltd
Supriya Lifescience standalone net profit ris..
10-Feb-2026
Read More
Supriya Lifescience Ltd
Supriya Lifescience standalone net profit rises 6.20% in the December 2025 quarter
Net profit of Supriya Lifescience rose 6.20% to Rs 49.68 crore in the quarter ended December 2025 as against Rs 46.78 crore during the previous quarter ended December 2024. Sales rose 11.20% to Rs 206.44 crore in the quarter ended December 2025 as against Rs 185.65 crore during the previous quarter ended December 2024.
Particulars
Quarter Ended
Dec. 2025
Dec. 2024
% Var.
Sales
206.44
185.65
11
OPM %
34.92
35.52
-
PBDT
74.20
67.54
10
PBT
67.38
62.58
8
NP
49.68
46.78
6
Supriya Lifescience Ltd
Supriya Lifesciences to discuss results
03-Feb-2026
Read More
Supriya Lifescience Ltd
Supriya Lifesciences to discuss results
Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 9 February 2026.
Supriya Lifescience Ltd
Supriya Lifescience standalone net profit ris..
13-Nov-2025
Read More
Supriya Lifescience Ltd
Supriya Lifescience standalone net profit rises 9.27% in the September 2025 quarter
Net profit of Supriya Lifescience rose 9.27% to Rs 50.43 crore in the quarter ended September 2025 as against Rs 46.15 crore during the previous quarter ended September 2024. Sales rose 20.31% to Rs 199.83 crore in the quarter ended September 2025 as against Rs 166.10 crore during the previous quarter ended September 2024.
Particulars
Quarter Ended
Sep. 2025
Sep. 2024
% Var.
Sales
199.83
166.10
20
OPM %
36.36
38.96
-
PBDT
74.96
66.81
12
PBT
68.32
62.07
10
NP
50.43
46.15
9
Supriya Lifescience Ltd
Supriya Lifesciences to hold board meeting
06-Nov-2025
Read More
Supriya Lifescience Ltd
Supriya Lifesciences to hold board meeting
Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 12 November 2025.
Supriya Lifescience Ltd
Supriya Lifescience Ltd - Announcement under ..
01-Oct-2025
Read More
Supriya Lifescience Ltd
Supriya Lifescience Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Completion of WHO GMP audit at Ambernath facility of the Company and receipt of WHO GMP Certificate for Inhalation Dosages.
Supriya Lifescience Ltd
Supriya Lifescience Ltd - Supriya Lifescience..
29-Sep-2025
Read More
Supriya Lifescience Ltd
Supriya Lifescience Ltd - Supriya Lifescience Limited - Trading Window
Supriya Lifescience Limited has informed the Exchange about Closure of Trading Window
Supriya Lifescience Ltd
Supriya Lifescience Ltd - Supriya Lifescience..
26-Sep-2025
Read More
Supriya Lifescience Ltd
Supriya Lifescience Ltd - Supriya Lifescience Limited - Trading Window
Supriya Lifescience Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Supriya Lifescience Ltd
Supriya Lifescience Ltd - Supriya Lifescience..
11-Sep-2025
Read More
Supriya Lifescience Ltd
Supriya Lifescience Ltd - Supriya Lifescience Limited - Reply to Clarification- Financial results
The Exchange had sought clarification from Supriya Lifescience Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed.
Supriya Lifescience Ltd
Supriya Lifescience Ltd - Supriya Lifescience..
11-Sep-2025
Read More
Supriya Lifescience Ltd
Supriya Lifescience Ltd - Supriya Lifescience Limited - Clarification - Financial Results
The Exchange has sought clarification from Supriya Lifescience Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Supriya Lifescience Ltd
Supriya Lifesciences to hold AGM
03-Sep-2025
Read More
Supriya Lifescience Ltd
Supriya Lifesciences to hold AGM
Supriya Lifesciences announced that the Annual General Meeting(AGM) of the company will be held on 24 September 2025.
Corporate Details
Board of Directors
Incorporation Year
2008
Chairman
Satish Waman Wagh
Auditor
Kakaria & Associates LLP
Face Value
2
Market Lot
1
Listing
BSE,NSE,
Registered Office
NA
Contact
Telephone: 91-22-40332727
Fax:
Chairman / Executive Director / Managing Director
Satish Waman Wagh
E D & Wholetime Director
Smita Satish Wagh
Saloni Satish Wagh
Shivani Satish Wagh
Balasaheb G. Sawant
Independent Non Exe. Director
Neelam Yashpal Arora
Ganapati D Yadav
Sunil Subhash Bhagwat
Company Sec. & Compli. Officer
Prachi Sathe
Additional Independent Director
MANISH ISHWARLAL PANCHAL
Kothandaraman Hari
Mutual Fund Holdings
1-10
of 15
Scheme Name
Amount Invested (Cr )
% Net Assets
Total Nav (Cr)
Abakkus Flexi Cap Fund
34.36
1.12
3,073.12
ITI Large & Mid Cap Fund
11.98
1.61
745.18
Quantum Small Cap Fund
6.77
3.57
189.79
ITI ELSS Tax Saver Fund
5.99
1.44
417.72
Motilal Oswal Nifty Microcap 250 Index Fund
5.31
0.23
2,292.27
WhiteOak Capital Pharma and Healthcare Fund
4.46
0.84
533.05
ITI Pharma and Healthcare Fund
1.66
0.75
221.78
Motilal Oswal BSE Healthcare ETF
0.05
0.12
42.77
Groww Nifty Total Market Index Fund
0.03
0.01
340.60
Bandhan BSE Healthcare Index Fund
0.02
0.12
16.75
FAQ
What is the share price of Supriya Lifescience Ltd today on NSE and BSE?
The Supriya Lifescience Ltd Share price on NSE is Rs.612.20 and BSE Rs.612.10 as on today
How to buy Supriya Lifescience Ltd shares Online?
You can easily open a Demat account online with Geojit and buy Supriya Lifescience Ltd shares through Flip/Selfie – Geojit’s advanced trading platform.
What is the Market Capitalization of Supriya Lifescience Ltd?
Market capitalization is a way of evaluating the value of a company. It refers to the total value of all a company's shares of stock. The market capitalization of Supriya Lifescience Ltd is 4926.35
What are the key financial ratios to analyse Supriya Lifescience Ltd Share Price?
Supriya Lifescience Ltd share can be evaluated based on following ratios as on March 2023
Shares P/E ratio: 26.54
ROE ratio: 20.74
Debt to Equity ratio: 0.01
EPS: 23.06
When did Supriya Lifescience Ltd gave bonus shares last?
The issue of bonus shares enhances the company's value and improve positions in the market by gaining the trust of existing shareholders. The Supriya Lifescience Ltd issued bonus shares last in NA
What is the 52 week highest and lowest share price value of Supriya Lifescience Ltd?
The highest share price value is Rs. 842.00 and Lowest share price value is Rs. 545.50 for 52 week period for Supriya Lifescience Ltd.
Which ETF or Mutual Fund Holding has the highest amount invested with Supriya Lifescience Ltd?
Abakkus Flexi Cap Fund has the highest amount invested with Supriya Lifescience Ltd.
Which year Supriya Lifescience Ltd was incorporated?
Supriya Lifescience Ltd was incorporated in 2008
What is the stock symbol of Supriya Lifescience Ltd?
The stock symbol for Supriya Lifescience Ltd shares is SUPRIYALIFESCIENCELTD.
Peer Comparison
Option Type
Balance Sheet
Financial Ratios
Profit & Loss
Select
Company Name
BSE Code
NSE Symbol
Aarti Pharmalabs Ltd
543748
AARTIPHARM
Accent Microcell Ltd
92465
ACCENTMIC
Accretion Pharmaceuticals Ltd
94000
ACCPL
Achyut Healthcare Ltd
543499
Not Listed
Advanced Enzyme Technologies Ltd
540025
ADVENZYMES
Akums Drugs & Pharmaceuticals Ltd
544222
AKUMS
Albert David Ltd
524075
ALBERTDAVD
Alembic Pharmaceuticals Ltd
533573
APLLTD
Alivus Life Sciences Ltd
543322
ALIVUS
Alkem Laboratories Ltd
539523
ALKEM
Please wait ...
Deliverable Volumes
Exchange
BSE
NSE
From Date
To Date
Date
Quantity Traded
Quantity Delivered
Change %
No Data Found For Deliverable Volume
Please wait ...